Lexicon Pharmaceuticals logo

Lexicon Pharmaceuticals share price today

(LXRX)

Lexicon Pharmaceuticals share price is $0.91 & ₹78.09 as on 7 Jan 2025, 2.30 'hrs' IST

$0.91

0.13

(15.94%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Lexicon Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Lexicon Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Lexicon Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Lexicon Pharmaceuticals share price movements

  • Today's Low: $0.80
    Today's High: $0.92

    Day's Volatility :12.49%

  • 52 Weeks Low: $0.62
    52 Weeks High: $3.73

    52 Weeks Volatility :83.37%

Lexicon Pharmaceuticals Returns

PeriodLexicon Pharmaceuticals, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-53.06%
-8.4%
0.0%
6 Months
-50.71%
-3.8%
0.0%
1 Year
-48.46%
-0.1%
0.0%
3 Years
-77.97%
2.9%
-19.8%

Lexicon Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$0.7886
Open
$0.8114
Today's High
$0.9154
Today's Low
$0.8011
Market Capitalization
$267.0M
Today's Volume
$3.1M
52 Week High
$3.73
52 Week Low
$0.6204
Revenue TTM
$5.2M
EBITDA
$-210.6M
Earnings Per Share (EPS)
$-0.74
Profit Margin
0.0%
Quarterly Earnings Growth YOY
-0.63%
Return On Equity TTM
-136.09%

How to invest in Lexicon Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Lexicon Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lexicon Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Lexicon Pharmaceuticals or LXRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lexicon Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Lexicon Pharmaceuticals shares which would translate to 0.943 fractional shares of Lexicon Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Lexicon Pharmaceuticals, in just a few clicks!

Returns in Lexicon Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lexicon Pharmaceuticals investment value today

Current value as on today

₹62,700

Returns

₹37,300

(-37.3%)

Returns from Lexicon Pharmaceuticals Stock

₹40,523 (-40.52%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Lexicon Pharmaceuticals

-2%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Lexicon Pharmaceuticals on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -2% less investors are searching Lexicon Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Lexicon Pharmaceuticals

  • Artal Group S A

    37.67%

  • FMR Inc

    13.79%

  • Siren, L.L.C.

    10.77%

  • Orbimed Advisors, LLC

    3.05%

  • BlackRock Inc

    2.74%

  • Vanguard Group Inc

    2.24%

Analyst Recommendation on Lexicon Pharmaceuticals

Buy

    72%Buy

    27%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Lexicon Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
7
7
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Lexicon Pharmaceuticals

What analysts predicted

Upside of 295.6%

Current:

$0.91

Target:

$3.60

Insights on Lexicon Pharmaceuticals

  • Price Movement

    In the last 7 days, LXRX stock has moved up by 9.6%
  • Increasing Revenue

    Revenue is up for the last 5 quarters, 162.0K → 1.75M (in $), with an average increase of 38.0% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -48.24M → -64.81M (in $), with an average decrease of 10.7% per quarter
  • LXRX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 70.2%
  • LXRX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 133.1%
  • Price to Sales

    ForLXRX every $1 of sales, investors are willing to pay $43.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Lexicon Pharmaceuticals Financials in INR & Dollars

FY18Y/Y Change
Revenue
$63.2M
↓ 30.03%
Net Income
$-120.5M
↓ 6.59%
Net Profit Margin
-190.71%
↓ 47.85%
FY19Y/Y Change
Revenue
$322.1M
↑ 409.54%
Net Income
$130.1M
↓ 207.95%
Net Profit Margin
40.4%
↑ 231.11%
FY20Y/Y Change
Revenue
$24.0M
↓ 92.55%
Net Income
$-70.2M
↓ 153.93%
Net Profit Margin
-292.49%
↓ 332.89%
FY21Y/Y Change
Revenue
$298.0K
↓ 98.76%
Net Income
$-88.3M
↑ 25.77%
Net Profit Margin
-29.6K%
↓ 29327.64%
FY22Y/Y Change
Revenue
$139.0K
↓ 53.36%
Net Income
$-103.1M
↑ 16.84%
Net Profit Margin
-74.2K%
↓ 44572.68%
FY23Y/Y Change
Revenue
$1.2M
↑ 766.19%
Net Income
$-177.1M
↑ 71.75%
Net Profit Margin
-14.7K%
↑ 59481.93%
Q2 FY23Q/Q Change
Revenue
$317.0K
↑ 1220.83%
Net Income
$-44.9M
↑ 45.3%
Net Profit Margin
-14.2K%
↑ 114605.53%
Q3 FY23Q/Q Change
Revenue
$162.0K
↓ 48.9%
Net Income
$-50.5M
↑ 12.52%
Net Profit Margin
-31.2K%
↓ 17022.97%
Q4 FY23Q/Q Change
Revenue
$702.0K
↑ 333.33%
Net Income
$-48.2M
↓ 4.51%
Net Profit Margin
-6.9K%
↑ 24315.91%
Q1 FY24Q/Q Change
Revenue
$1.1M
↑ 60.97%
Net Income
$-48.4M
↑ 0.32%
Net Profit Margin
-4.3K%
↑ 2589.44%
Q2 FY24Q/Q Change
Revenue
$1.6M
↑ 45.75%
Net Income
$-53.4M
↑ 10.4%
Net Profit Margin
-3.2K%
↑ 1038.9%
Q3 FY24Q/Q Change
Revenue
$1.8M
↑ 6.25%
Net Income
$-64.8M
↑ 21.3%
Net Profit Margin
-3.7K%
↓ 459.47%
FY18Y/Y Change
Profit
$60.7M
↓ 31.34%
FY19Y/Y Change
Profit
$318.8M
↑ 425.12%
FY20Y/Y Change
Profit
$22.1M
↓ 93.08%
FY21Y/Y Change
Profit
$-54.7M
↓ 348.11%
FY22Y/Y Change
Profit
$-288.0K
↓ 99.47%
FY23Y/Y Change
Profit
$1.1M
↓ 488.54%
Q2 FY23Q/Q Change
Profit
$309.0K
↓ 451.14%
Q3 FY23Q/Q Change
Profit
$155.0K
↓ 49.84%
Q4 FY23Q/Q Change
Profit
$485.0K
↑ 212.9%
Q1 FY24Q/Q Change
Profit
$955.0K
↑ 96.91%
Q2 FY24Q/Q Change
Profit
$1.5M
↑ 55.08%
Q3 FY24Q/Q Change
Profit
$1.7M
↑ 13.37%
FY18Y/Y Change
Operating Cash Flow
$-148.6M
↓ 19.84%
Investing Cash Flow
$169.6M
↑ 235.65%
Financing Cash Flow
$-2.2M
↓ 101.5%
FY19Y/Y Change
Operating Cash Flow
$113.8M
↓ 176.58%
Investing Cash Flow
$-155.9M
↓ 191.91%
Financing Cash Flow
$-2.2M
↓ 0.8%
FY20Y/Y Change
Operating Cash Flow
$-143.0M
↓ 225.62%
Investing Cash Flow
$380.8M
↓ 344.3%
Financing Cash Flow
$-147.6M
↑ 6532.35%
FY21Y/Y Change
Operating Cash Flow
$-87.0M
↓ 39.14%
Investing Cash Flow
$2.1M
↓ 99.45%
Financing Cash Flow
$22.7M
↓ 115.38%
FY22Y/Y Change
Operating Cash Flow
$-88.9M
↑ 2.11%
Investing Cash Flow
$-71.1M
↓ 3468.63%
Financing Cash Flow
$142.2M
↑ 526.22%
Q2 FY23Q/Q Change
Operating Cash Flow
$-38.1M
↑ 20.57%
Investing Cash Flow
$-74.6M
↓ 716.95%
Financing Cash Flow
$189.0M
↓ 23036.29%

Lexicon Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Lexicon Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Lexicon Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Lexicon Pharmaceuticals, Inc.
7.13%
-50.71%
-48.46%
-77.97%
-80.72%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Lexicon Pharmaceuticals, Inc.
NA
NA
-0.14
-0.69
-1.36
-0.44
NA
0.49
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Lexicon Pharmaceuticals, Inc.
Buy
$267.0M
-80.72%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Lexicon Pharmaceuticals

corporate overview lexicon pharmaceuticals is a biopharmaceutical company that has harnessed the power of genetics for drug discovery. our research team has generated a pipeline of novel drug candidates in clinical development across a broad range of indications. the genome: our source of discovery we have applied gene knockout technology to thousands of potential drug targets encoded in the human genome. our scientists have gained a thorough understanding of target biology and identified new points of intervention for future therapies. we have integrated a series of recombinant dna and chemistry technologies into a systematic drug discovery and development process. our unique knowledge of targets from the human genome has allowed us to better evaluate and advance novel drug candidates with great promise for patients. a diverse pipeline of targeted therapies our genomics-based approach to drug discovery has enabled our scientists to select drug targets across a broad range of indicatio
Organization
Lexicon Pharmaceuticals
Employees
285
CEO
Mr. Brian T. Crum
Industry
Health Technology

Management People of Lexicon Pharmaceuticals

NameTitle
Mr. Brian T. Crum
Senior VP, General Counsel & Secretary
Dr. Alan J. Main Ph.D.
Executive Vice President of Innovation & Chemical Sciences
Dr. Craig B. Granowitz M.D., Ph.D.
Senior VP & Chief Medical Officer
Dr. Michael Exton Ph.D.
CEO & Director
Ms. Kristen L. Alexander
Vice President of Finance & Accounting
Ms. Lisa M. DeFrancesco
Vice President of Investor Relations & Corporate Communications
Mr. Dixon Terry
Vice President of Compliance
Ms. Carrie Siragusa
Vice President of Marketing
Ms. Desiree Gendron
Vice President of Sales & Training
Ms. Wendy E. McDermott
Senior Vice President of Human Resources

Important FAQs about investing in Lexicon Pharmaceuticals from India :

What is Lexicon Pharmaceuticals share price today?

Lexicon Pharmaceuticals share price today stands at $0.91, Open: $0.81 ; Previous Close: $0.79 ; High: $0.92 ; Low: $0.80 ; 52 Week High: $3.73 ; 52 Week Low: $0.62. The stock opens at $0.81, after a previous close of $0.79. The stock reached a daily high of $0.92 and a low of $0.80, with a 52-week high of $3.73 and a 52-week low of $0.62.

Can Indians buy Lexicon Pharmaceuticals shares?

Yes, Indians can invest in the Lexicon Pharmaceuticals (LXRX) from India.

With INDmoney, you can buy Lexicon Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Lexicon Pharmaceuticals at zero transaction cost.

How can I buy Lexicon Pharmaceuticals shares from India?

It is very easy to buy Lexicon Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lexicon Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Lexicon Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Lexicon Pharmaceuticals stocks?

To start investing in Lexicon Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Lexicon Pharmaceuticals

Today’s highest price of Lexicon Pharmaceuticals (LXRX) is $0.92.

Today’s lowest price of Lexicon Pharmaceuticals (LXRX) is $0.80.

What is today's market capitalisation of Lexicon Pharmaceuticals

Today's market capitalisation of Lexicon Pharmaceuticals LXRX is 267.0M

What is the 52 Week High and Low Range of Lexicon Pharmaceuticals

  • 52 Week High

    $3.73

  • 52 Week Low

    $0.62

What are the historical returns of Lexicon Pharmaceuticals?

  • 1 Month Returns

    7.13%

  • 3 Months Returns

    -50.71%

  • 1 Year Returns

    -48.46%

  • 5 Years Returns

    -80.72%

Who is the Chief Executive Officer (CEO) of Lexicon Pharmaceuticals

Mr. Brian T. Crum is the current Chief Executive Officer (CEO) of Lexicon Pharmaceuticals.